Alvotech (ALVO) Research & Development (2021 - 2026)
Alvotech (ALVO) recorded Research & Development of -$21.86 million in Q2 2026, compared with -$54.72 million a year earlier.
Powered by 
Analysis
Alvotech (ALVO) Research & Development (2021 - 2026) Analysis & Trends
On a TTM basis, Alvotech's Research & Development came in at -$46.37 million as of Jun 30, 2026; for FY2025, it came in at -$184.19 million.
- Across earlier years, Research & Development came in at -$171.31 million in FY2024, -$210.83 million in FY2023, -$180.62 million in FY2022 and -$191.01 million in FY2021.
- Quarterly Research & Development has ranged from -$210.83 million in Q1 2023 to $267.51 million in Q2 2022 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$24.51 million (Q1 2026), $51.62 million (Q4 2025) and -$51.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Alvotech | 1.35 Bn | 919.66 Mn | 2.56 Mn | 21.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.86 Mn |
| Mar 31, 2026 | 24.51 Mn |
| Dec 31, 2025 | -51.62 Mn |
| Sep 30, 2025 | 51.62 Mn |
| Jun 30, 2025 | 54.72 Mn |
| Mar 31, 2025 | 38.17 Mn |
| Dec 31, 2024 | 40.26 Mn |
| Sep 30, 2024 | 33.57 Mn |
| Jun 30, 2024 | 47.61 Mn |
| Mar 31, 2024 | 49.87 Mn |
| Dec 31, 2023 | 58.01 Mn |
| Sep 30, 2023 | 53.23 Mn |
| Jun 30, 2023 | 48.72 Mn |
| Mar 31, 2023 | 50.86 Mn |
| Dec 31, 2022 | 180.62 Mn |
| Sep 30, 2022 | 46.26 Mn |
| Jun 30, 2022 | 39.75 Mn |
| Mar 31, 2022 | 47.14 Mn |
| Dec 31, 2021 | 191.01 Mn |
| Sep 30, 2021 | 56.20 Mn |
API Access
Alvotech Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ALVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ALVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ALVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();